Cite Filings / MDGL / 0001193125-23-295310

Feed Companies Filings Check

Sign in

CORRESP

Correspondence Between Filers and SEC Staff

MADRIGAL PHARMACEUTICALS, INC. Filed 2023-12-14 Acc 0001193125-23-295310

Documents 1

CORRESP Correspondence Between Filers and SEC Staff , filename1.htm

Around this filing

2024-01-17 CORRESP Correspondence Between Filers and SEC Staff
2023-12-14 4 Director bought 101,792 shares at an average $221.20 ($22,516,577)
2023-12-14 4 Director bought 34,578 shares at an average $218.31 ($7,548,616)
2023-12-14 CORRESP Correspondence Between Filers and SEC Staff
2023-12-14 4 Senior VP, Chief Pharma Dev. sold 3,800 shares at an average $222.82 ($846,700)
2023-12-13 SC 13D/A Beneficial Ownership Report
2023-12-08 CORRESP Correspondence Between Filers and SEC Staff

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading filename1.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…